- Home
- AVIR vs MVIS Comparison
AVIR vs MVIS Comparison
Compare AVIR & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | MVIS |
|---|---|---|
| Founded | 2012 | 1993 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.0M | 271.6M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | AVIR | MVIS |
|---|---|---|
| Price | $4.74 | $0.81 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $6.00 | $2.50 |
| AVG Volume (30 Days) | 580.2K | ★ 4.3M |
| Earning Date | 04-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | $664,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $461.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.46 | $0.65 |
| 52 Week High | $4.70 | $1.77 |
Technical Indicators
Market Signals| Indicator | AVIR | MVIS |
|---|---|---|
| Relative Strength Index (RSI) | 71.86 | 50.40 |
| Support Level | $4.04 | $0.74 |
| Resistance Level | $4.50 | $0.82 |
| Average True Range (ATR) | 0.24 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 93.23 | 76.55 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.